Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, August 16 '25)

Image
By G.M.

 


    Am J Obstet Gynecol

  1. DALRYMPLE KV, Tydeman F, Bone JN, Poston L, et al
    The relationship between virtual antenatal care and pregnancy outcomes in a diverse UK inner-city population; A group-based trajectory modelling approach using routine health records.
    Am J Obstet Gynecol. 2025 Aug 11:S0002-9378(25)00538.
    PubMed         Abstract available


    Br J Anaesth

  2. WATSON SL, Fowler AJ, Pearse RM, Abbott TEF, et al
    The financial cost of postoperative complications: a prospective cohort study with linked health systems data.
    Br J Anaesth. 2025 Aug 8:S0007-0912(25)00467-2. doi: 10.1016/j.bja.2025.
    PubMed         Abstract available


    Int J Infect Dis

  3. TURJEMAN A, Drozdinsky G, Leibovici L
    The Impact of the COVID-19 Pandemic on Influenza Vaccination: A Multi-Year Interrupted Time Series Analysis.
    Int J Infect Dis. 2025 Aug 11:108015. doi: 10.1016/j.ijid.2025.108015.
    PubMed         Abstract available

  4. CARAZO S, Ouakki M, Nicolakakis N, Falcone EL, et al
    Long COVID risk and severity after COVID-19 infections and reinfections: a retrospective cohort study among healthcare workers.
    Int J Infect Dis. 2025 Aug 7:108012. doi: 10.1016/j.ijid.2025.108012.
    PubMed         Abstract available


    J Infect

  5. LI Z, Wang X, Chen S, Xiong W, et al
    Assessing Global Border Controls in Response to COVID-19 Pandemic Using Real-World Data and Target Trial Emulation.
    J Infect. 2025 Aug 12:106578. doi: 10.1016/j.jinf.2025.106578.
    PubMed         Abstract available

  6. BUTLER CC, Hobbs FDR, Little P, Richards D, et al
    Removal notice to "Ivermectin and COVID-19" Journal of Infection 91 (2025) 106530.
    J Infect. 2025;91:106579.
    PubMed        

  7. JANANI L, Munro APS, Wright A, Aley PK, et al
    Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: results from COV-BOOST trial.
    J Infect. 2025 Aug 7:106576. doi: 10.1016/j.jinf.2025.106576.
    PubMed         Abstract available


    J Med Virol

  8. WU Z, Jiang H, Zhou Y, Yang Y, et al
    A Clinical Investigation Into the Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Vaccination in Children With Acute Lymphoblastic Leukemia.
    J Med Virol. 2025;97:e70492.
    PubMed         Abstract available


    J Travel Med

  9. PERLANT C, Klitting R, Colizza V, Gaythorpe KAM, et al
    A framework to assess the risk of Yellow Fever emergence.
    J Travel Med. 2025 Aug 6:taaf081. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  10. SUGIURA Y, Takahashi T, Ueno S, Amarbayasgalan S, et al
    Expression of spike and hemagglutinin-esterase proteins is necessary to recover infectious recombinant bovine coronavirus.
    J Virol. 2025 Aug 11:e0102725. doi: 10.1128/jvi.01027.
    PubMed         Abstract available

  11. XIAO W, Xiong Y, Wang Y, Li T, et al
    Cathepsin L and transmembrane serine protease 11E mediate trypsin-independent entry of porcine deltacoronavirus into Huh7 cells.
    J Virol. 2025 Aug 11:e0105525. doi: 10.1128/jvi.01055.
    PubMed         Abstract available

  12. KARIMI A, Lieber CM, Sakamoto K, Plemper RK, et al
    SARS-CoV-2 causes chronic lung inflammation and impaired respiratory capacity in aged Roborovski dwarf hamsters.
    J Virol. 2025 Aug 11:e0075525. doi: 10.1128/jvi.00755.
    PubMed         Abstract available


    Lancet Infect Dis

  13. LIU C, Rosen EA, Stohs EJ, Imlay H, et al
    Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship.
    Lancet Infect Dis. 2025 Aug 11:S1473-3099(25)00311.
    PubMed         Abstract available

  14. RANSCOMBE P
    The quirky story behind New York's SARS-CoV-2 preparations.
    Lancet Infect Dis. 2025 Aug 8:S1473-3099(25)00505.
    PubMed        

  15. NGUYEN-TRAN H, Park SW, Vogt MR, Permaul P, et al
    Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022-23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance study.
    Lancet Infect Dis. 2025 Aug 6:S1473-3099(25)00349.
    PubMed         Abstract available


    Travel Med Infect Dis

  16. NEUMANN JA, Zimmermann J, Frese M, Dirksen-Fischer M, et al
    Infectious diseases on passenger ships: Port preparedness and response - A narrative systematic review.
    Travel Med Infect Dis. 2025;67:102886.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »